Office of Oncology Drug Products Divisions and Programs

The Office of Oncology Drug Products (OODP) is responsible for making safe and effective drug and therapeutic biologic treatments for cancer available to the U.S. public. OODP has the following components:

• Immediate Office
• Division of Biologic Oncology Products
• Division of Drug Oncology Products
• Division of Medical Imaging and Hematology Products
• Oncology Program
• Radioactive Drug Research Committee Program
• CDER Organizational Charts
• CDER Offices and Divisions

PDF requires the free Adobe Acrobat Reader